Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes, 62397-62398 [2023-19536]

Download as PDF 62397 Federal Register / Vol. 88, No. 174 / Monday, September 11, 2023 / Notices import, and export regulated transactions in listed chemicals are submitted electronically through the Diversion Control Division secure network application. Any person who desires to import non-narcotic substances in schedules III, IV, and V must electronically file their return information. Any person who desires to export non-narcotic substances in schedules III and IV and any other substance in schedule V is also required to electronically file a controlled substances import declaration/ controlled substance export invoice. Overview of This Information Collection 1. Type of Information Collection: Extension of a previously approved collection. 2. The Title of the Form/Collection: Import/Export Declaration for List I and List II Chemicals. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms: 486, 486A. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as the obligation to respond: Affected Public (Primary): Private Sector—businesses or other for-profit institutions, and not-forprofit institutions. Other: State, local and tribal governments, Federal Government. The obligation to respond is mandatory per 21 CFR part 1313. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 631 registrants participate in this information collection. The time per response is 11 minutes to complete the DEA–486 Import, DEA–486 International, and DEA–486A Import. The time per response is 12 minutes to complete DEA–486 Export. 6. An estimate of the total annual burden (in hours) associated with the collection: DEA estimates that this collection takes 4,134 annual burden hours. 7. An estimate of the total annual cost burden associated with the collection, if applicable: $0. TOTAL BURDEN HOURS Number of respondents Activity Total annual responses Time per response (minutes) Total annual burden (hours) DEA–486 Import .................................................................. DEA–486 Export .................................................................. DEA–486 International ......................................................... DEA–486A Import ................................................................ 164 204 99 164 16 77 4 16 2,686 15,737 429 2,686 11 12 11 11 457 3,147 73 457 Unduplicated Totals ...................................................... 631 34 21,538 ........................ 4,134 If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 4W–218, Washington, DC. Dated: September 5, 2023. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2023–19539 Filed 9–8–23; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0013] ddrumheller on DSK120RN23PROD with NOTICES1 Frequency Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the SUMMARY: VerDate Sep<11>2014 18:16 Sep 08, 2023 Jkt 259001 following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until November 13, 2023. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261, Email: scott.a.brinks@ dea.gov. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the SUPPLEMENTARY INFORMATION: PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Abstract: Section 1002 of the Controlled Substances Import and Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal Regulations 21 CFR, sections 1312.11, 1312.12 and 1312.13 requires any person who desires to import controlled substances listed in schedules I or II, any narcotic substance listed in schedules III or IV, or any non-narcotic substance in schedule III which the Administrator has specifically designated by regulation in section 1312.30, or any nonnarcotic E:\FR\FM\11SEN1.SGM 11SEN1 62398 Federal Register / Vol. 88, No. 174 / Monday, September 11, 2023 / Notices substance in schedule IV or V which is also listed in schedule I or II of the Convention on Psychotropic Substances, must have an import permit. To obtain the permit to import controlled substances for domestic and or scientific purposes, an application for the permit must be made to the DEA, on DEA Form 357. Overview of This Information Collection 1. Type of Information Collection: Extension of a previously approved collection. 2. The Title of the Form/Collection: Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Form 357. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as the obligation to respond: Affected Public: Private Sector—businesses or other forprofit institutions. The obligation to respond is mandatory per 21 CFR, sections 1312.11, 1312.12 and 1312.13. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 124 registrants participate in this information collection. The time per response is 21 minutes to complete the DEA–357 (paper) and 15 minutes to complete DEA–357 (online). 6. An estimate of the total annual burden (in hours) associated with the collection: DEA estimates that this collection takes 264.35 annual burden hours. 7. An estimate of the total annual cost burden associated with the collection, if applicable: $0. TOTAL BURDEN HOURS Number of respondents Activity Time per response (min.) Total annual burden (hours) DEA Form: 357 (online) ....................................................... DEA Form: 357 (paper) ....................................................... 124 9 958 71 15 21 266 19 Unduplicated Totals ...................................................... 124 ........................ 1,081 0.26 264.35 If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 4W–218, Washington, DC. Dated: September 5, 2023. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2023–19536 Filed 9–8–23; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0024] Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Report of Loss or Disappearance of Listed Chemicals and Regulated Transactions in Tableting/ Encapsulating Machines Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: ddrumheller on DSK120RN23PROD with NOTICES1 Total annual responses Frequency The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in SUMMARY: VerDate Sep<11>2014 17:10 Sep 08, 2023 Jkt 259001 accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until November 13, 2023. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A Brinks, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261, Email: scott.a.brinks@ dea.gov. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; SUPPLEMENTARY INFORMATION: PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Abstract: Each regulated person is required to report any unusual or excessive loss or disappearance of a listed chemical, and any regulated transaction in a tableting or encapsulating machine, to include any domestic regulated transaction in a tableting or encapsulating machine and any import or export of a tableting or encapsulating machine. 21 U.S.C. 830 (b)(1)(A), (C) and (D); 21 CFR 1310.05(a)(1), (3)–(4); 21 CFR 1310.05(c). Regulated persons include manufacturers, distributors, importers, and exporters of listed chemicals, tableting machines, or encapsulating machines, or persons who serve as brokers or traders for international transactions involving a listed chemical, tableting machine, or encapsulating machine. 21 CFR 1300.02(b). This report will be submitted electronically. DEA will be modifying this collection (1117– 0024) and collection 1117–0001 by removing Form 107 from this collection and adding it to 1117–0001 because E:\FR\FM\11SEN1.SGM 11SEN1

Agencies

[Federal Register Volume 88, Number 174 (Monday, September 11, 2023)]
[Notices]
[Pages 62397-62398]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19536]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0013]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Extension of a Previously Approved Collection; 
Application for Permit To Import Controlled Substances for Domestic 
and/or Scientific Purposes

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA), Department of 
Justice (DOJ), will be submitting the following information collection 
request to the Office of Management and Budget (OMB) for review and 
approval in accordance with the Paperwork Reduction Act of 1995.

DATES: Comments are encouraged and will be accepted for 60 days until 
November 13, 2023.

FOR FURTHER INFORMATION CONTACT: If you have additional comments 
especially on the estimated public burden or associated response time, 
suggestions, or need a copy of the proposed information collection 
instrument with instructions or additional information, please contact 
Scott A. Brinks, Regulatory Drafting and Policy Support Section, Drug 
Enforcement Administration; Mailing Address: 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 362-3261, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the Bureau of Justice 
Statistics, including whether the information will have practical 
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Abstract: Section 1002 of the Controlled Substances Import and 
Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal 
Regulations 21 CFR, sections 1312.11, 1312.12 and 1312.13 requires any 
person who desires to import controlled substances listed in schedules 
I or II, any narcotic substance listed in schedules III or IV, or any 
non-narcotic substance in schedule III which the Administrator has 
specifically designated by regulation in section 1312.30, or any 
nonnarcotic

[[Page 62398]]

substance in schedule IV or V which is also listed in schedule I or II 
of the Convention on Psychotropic Substances, must have an import 
permit. To obtain the permit to import controlled substances for 
domestic and or scientific purposes, an application for the permit must 
be made to the DEA, on DEA Form 357.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a previously 
approved collection.
    2. The Title of the Form/Collection: Application for Permit to 
Import Controlled Substances for Domestic and/or Scientific Purposes.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form 357. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Office of Diversion Control.
    4. Affected public who will be asked or required to respond, as 
well as the obligation to respond: Affected Public: Private Sector--
businesses or other for-profit institutions. The obligation to respond 
is mandatory per 21 CFR, sections 1312.11, 1312.12 and 1312.13.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 124 registrants participate in this information collection. The 
time per response is 21 minutes to complete the DEA-357 (paper) and 15 
minutes to complete DEA-357 (online).
    6. An estimate of the total annual burden (in hours) associated 
with the collection: DEA estimates that this collection takes 264.35 
annual burden hours.
    7. An estimate of the total annual cost burden associated with the 
collection, if applicable: $0.

                                               Total Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Time per
            Activity                 Number of       Frequency     Total annual      response      Total annual
                                    respondents                      responses        (min.)      burden (hours)
----------------------------------------------------------------------------------------------------------------
DEA Form: 357 (online)..........             124               9             958              15             266
DEA Form: 357 (paper)...........                                              71              21              19
                                 -------------------------------------------------------------------------------
    Unduplicated Totals.........             124  ..............           1,081            0.26          264.35
----------------------------------------------------------------------------------------------------------------

    If additional information is required contact: Darwin Arceo, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, 4W-218, Washington, DC.

    Dated: September 5, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2023-19536 Filed 9-8-23; 8:45 am]
BILLING CODE 4410-09-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.